Hinge Bio, Inc. is a privately-held biotechnology company leveraging its powerful GEM-⁠DIMER™ platform to develop therapeutics that address the problems of inadequate efficacy and resistance in infectious disease and oncology.

Biotechnology

Hinge Bio

Hinge Bio's headquarters in Burlingame, CA, United States

Harold E. Barry Selick

Juha Punnonen

Carin Rollins

Carin Mueller Rollins

Kristen Quigley

Joshua Carle

Miriam Siekevitz

Daniel Capon

Malcolm L. Gefter

J. Misha Petkevich

Bill Unger

Samuel Broder

Nicole Vitullo

The Leadership Team at Hinge Bio is responsible for setting strategic direction, overseeing the development of the GEM-DIMER™ platform, and ensuring the effective execution of research and manufacturing processes. Comprised of co-founders and vice presidents with diverse expertise in operations, scientific research, and legal affairs, the team drives innovation and navigates challenges in the biotechnology landscape to advance therapeutics for infectious diseases and oncology.

Leadership Team

The Development Team at Hinge Bio, Inc. spearheads the advancement of therapeutics utilizing the GEM-DIMER™ platform, focusing on combating efficacy challenges and resistance in infectious diseases and oncology. The team, led by the Chief Development Officer and VP of Development, collaborates closely with scientists to drive preclinical and clinical research initiatives, ensuring the progression from conceptualization to market-ready solutions.

Development Team

Hinge Bio

Org chart

Board & advisors

Teams

Leadership Team

Development Team

Offices

Hinge Bio

Org chart

Board & advisors

Teams

Leadership Team

Development Team

Offices

Related companies